Newscope Capital, whom is currently doing business as Pharmather (CSE: PHRM) is the latest firm to begin trading on the Canadian Securities Exchange, having made its debut Friday. The specialty life sciences firm is currently focused on research and development of psychedelic pharmaceuticals, while taking a novel approach to the FDA process. First and foremost, … Continue reading Pharmather: Combining Artificial Intelligence With Psychedelics For Novel Drug Discovery